Search Ontology:
ChEBI
nirmatrelvir
- Term ID
- CHEBI:170007
- Synonyms
-
- (1R,2S,5S)-N-{(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide
- nirmatrelvir
- nirmatrelvirum
- PF 07321332
- PF-07321332
- PF07321332
- Definition
- An azabicyclohexane that is (1R,5S)-3-azabicyclo[3.1.0]hexane substituted by {(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl}aminoacyl, 3-methyl-N-(trifluoroacetyl)-L-valinamide, methyl and methyl groups at positions 2S, 3, 6 and 6, respectively. It is the first orally administered inhibitor of SARS-CoV-2 main protease developed by Pfizer and used in combination with ritonavir for the treatment of COVID-19.
- References
-
- cas:2628280-40-8
- drugbank:DB16691
- kegg.drug:D12244
- pmc:PMC9232762
- pmc:PMC9264725
- pubmed:34687004
- pubmed:35073029
- pubmed:35153195
- pubmed:35182772
- pubmed:35183067
- pubmed:35203821
- pubmed:35305258
- pubmed:35335157
- pubmed:35389231
- pubmed:35425393
- pubmed:35461811
- pubmed:35477935
- pubmed:35505633
- pubmed:35640480
- pubmed:35678736
- pubmed:35702394
- pubmed:35845944
- pubmed:36276807
- pubmed:36574296
- pubmed:36965419
- pubmed:37074087
- pubmed:37402789
- pubmed:37510996
- pubmed:37947496
- pubmed:38257765
- pubmed:38399271
- pubmed:38432955
- pubmed:38553607
- wikipedia.en:Nirmatrelvir
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from nirmatrelvir
Phenotype where environments contain nirmatrelvir
Phenotype modified by environments containing nirmatrelvir
Phenotype affecting nirmatrelvir
Human Disease Model